February 26, 2022 - LIVESTREAM - CT
This livestream event seeks to educate and update clinicians, researchers, healthcare executives, and policy makers on the current state of therapeutic options for COVID-19 in 2022. This course will focus on the evolving utility of and data supporting the use of convalescent plasma in COVID-19 patients. The current regulatory framework and expanded access program will be discussed. In addition, indications, advances in, and appropriate candidates for monoclonal antibody therapy for at risk patients will be reviewed. The steps to build and manage the infusion program designed to treat the local area surrounding Mayo Clinic will be highlighted. Finally, a review of the latest data regarding the safety, efficacy, and future directions of vaccination for COVID-19 prevention will be given.